This year, several of our top stories on dry eye disease focused on sleep quality and treatment options, including supplements designed to reduce symptoms.
Another treatment option that made news early this year was Vevye (cyclosporine ophthalmic solution 0.1%, Harrow), which demonstrated high tolerability and rapid onset of relief.
Read below for summaries of these news stories and more.
Patients with dry eye disease have worse sleep quality and may be at greater risk for unhealthy sleep duration, although a causal relationship between dry eye and sleep disorder has not been established,